Forte Biosciences
FBRX
FBRX
31 hedge funds and large institutions have $3.6M invested in Forte Biosciences in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
–
Holders Change %
0%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
9
Closed
2
Calls
$160K
Puts
$1K
Net Calls
+$159K
Net Calls Change
+$126K
Top Buyers
Top Sellers
| 1 |
NM
1
Newtyn Management
New York
|
$0 |
| 2 |
2
Millennium Management
New York
|
$59.4K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$34 |
| 4 |
4
BlackRock
New York
|
$190K |
| 5 |
5
Renaissance Technologies
New York
|
$213K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $144 | +$24 | +1 | +20% |
|
27
Bank of America
Charlotte,
North Carolina
| $122 | -$220 | -9 | -64% |
|
|
28
UBS Group
Zurich,
Switzerland
| $34 | -$12.9K | -380 | -100% |
|
29
JPMorgan Chase & Co
New York
| $18 | – | – | – |
|
|
NM
30
Newtyn Management
New York
| – | -$415K | -16,430 | Closed |
|
|
LFG
31
Larson Financial Group
St Louis,
Missouri
| – | -$35 | -1 | Closed |
|